Sponsored Links

Soligenix Announces Publication Of Positive Stability Results With RiVax(TM), Its Vaccine Against Ricin Toxin PDF Print E-mail
Medical News - Bio-terrorism
Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biotechnology company, announced the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability...

Read more: Bio-terrorism / Terrorism News From Medical News Today